NSE filing, NSE: BALAXI. Summary written from the filing by ALFA Finder's alert engine.
Balaxi Pharmaceuticals Ltd: key numbers
- Share price
- ₹19.15
- Market cap
- ₹105.7 Cr
- Revenue (annual)
- ₹270.2 Cr
- Net profit (annual)
- ₹1.42 Cr
- P/E (TTM)
- 43.6×Sector 45.9×
- Promoter holding
- 65.99%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Balaxi Pharmaceuticals Ltd
All →Balaxi Pharmaceuticals Board Meeting Date
Balaxi Pharmaceuticals will meet on 12 November 2026 to approve unaudited half-year results. The trading window stays closed until 14 November 2026.
Balaxi Pharmaceuticals Other Announcement
Balaxi Pharmaceuticals Limited reported nil activity regarding the re-lodgement of physical share transfer requests for the period ended September 2026.
Balaxi Pharmaceuticals Other Announcement
Balaxi Pharmaceuticals reported nil activity regarding the re-lodgement of physical share transfer requests for August 2026. This is a routine regulatory compliance filing.
Balaxi Pharmaceuticals Business Update
Balaxi Pharmaceuticals has received WHO-GMP certification for its first pharmaceutical formulation manufacturing facility in Telangana. The facility has commenced manufacturing initially approved products for international markets.
Balaxi Pharmaceuticals Management Change
Balaxi Pharmaceuticals Limited shareholders approved the re-appointment of Ms. Akshita Ostwal as an Independent Director for a second five-year term starting September 5, 2026.
Balaxi Pharmaceuticals Annual General Meeting
Balaxi Pharmaceuticals Limited held its 83rd Annual General Meeting on August 24, 2026. Shareholders voted on financial statements and director re-appointments during the proceedings.
Other results correction announcements
All →Syschem (India) Results Correction
Syschem India re-submitted its unaudited Q2/H1 FY2026-27 standalone results with the limited review report, following a BSE query. Revenue from operations was Rs 12,979.28 lakh for the quarter, with profit of Rs 191.09 lakh.
Amalgamated Electricity Company Results Correction
Amalgamated Electricity revised its board outcome to correct a director's designation in the September 2026 balance sheet. The resubmission re-encloses the unaudited results and limited review report.
Manipal Payment and Identity Solutions Results Correction
Manipal Payment and Identity Solutions clarified two NSE observations on its 01 October 2026 financial results. It stated it has one operating segment and that the results PDF was machine-readable.
Tamilnad Mercantile Bank Results Correction
TMB clarified its ₹304.24 crore ECL provision is proactive, not a regulatory shortfall. The ECL framework applies from April 2027 under RBI rules.
Punjab National Bank Results Correction
Punjab National Bank re-submitted its unchanged September 2026 quarter and half-year results in machine-readable format. No figures, disclosures or other information were modified from the earlier filing.
Gateway Distriparks Results Correction
Gateway Distriparks issued a revised Q2 FY27 results press release to correct a typographical error in the earlier filing. The financial figures remain materially unchanged.